Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lilly Takes Separate Track On IG; Compliance Guide Is Not A PhRMA Issue

Executive Summary

Lilly plans to comment on the HHS Inspector General's pharmaceutical compliance guidance independent of an industry-wide compliance working group.

You may also be interested in...



Market Share-Based Rebates Are Not Rx Switch Deals, Manufacturers Argue

Drug rebates based on market share and payments to PBMs to disseminate product information are not switching arrangements, a group of 19 manufacturers maintain in comments on the HHS Inspector General's draft compliance guidance

Market Share-Based Rebates Are Not Rx Switch Deals, Manufacturers Argue

Drug rebates based on market share and payments to PBMs to disseminate product information are not switching arrangements, a group of 19 manufacturers maintain in comments on the HHS Inspector General's draft compliance guidance

IG Has Overly “Negative” View Of Sales Incentives, Pfizer Counsel Says

The HHS Inspector General's draft compliance guidance for the pharmaceutical industry takes an overly "negative" stance on compensation for sales representatives, Pfizer Corporate Compliance Counsel Doug Lankler said

Related Content

UsernamePublicRestriction

Register

LL111799

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel